Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL

Leukemia, Published online: 26 August 2023; doi:10.1038/s41375-023-02010-yPreclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL

Source: Leukemia - August 26, 2023 Category: Hematology Authors: Ze Tian Chunhua Shi Guojun Yang Jason K. Allen Qing Shi Amin AI-Shami Jill Wardell Olson Melinda G. Smith Qing Chang Jasbir Kaur Junping You Timothy E. Lofton Michelle A. Gonzalez Qi Zhang DongXing Zha Sarah K. Tasian Nitin Jain Marina Y. Konopleva Timoth Source Type: research